The Oncology Institute Warrant
TOIIW
TOIIW was delisted on the 31st of July, 2026.
14 hedge funds and large institutions have $132K invested in The Oncology Institute Warrant in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.33% less ownership
Funds ownership: 6.15% → 5.82% (-0.33%)
7% less funds holding
Funds holding: 15 → 14 (-1)
90% less capital invested
Capital invested by funds: $1.3M → $132K (-$1.16M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
+$5.21K |
| 2 |
Walleye Capital
New York
|
+$1.66K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$589 |
| 4 |
CAC
Cowen and Company
New York
|
+$17 |
| 5 |
CS
Clear Street
New York
|
+$11 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Difesa Capital Management
New York
|
-$1.83K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$6 |
TOIIW Hedge Fund Activity: Q2 2023 in Review
14 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q2 2023, worth a combined $132K — down 90% from $1.3M a quarter earlier.
Fund positioning in TOIIW was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 1 trimmed.
The largest buyer was Man Group, opening a new position worth an estimated $5.21K. The largest seller was Difesa Capital Management, cutting an estimated $1.83K.
- 14 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q2 2023, down from 15 in Q1 2023.
- Funds reported $132K of The Oncology Institute Warrant stock for Q2 2023, down 90% quarter-over-quarter.
- 1 fund opened new The Oncology Institute Warrant positions in Q2 2023 and 1 closed out, a net change of 0 holders.
- The largest The Oncology Institute Warrant buyer in Q2 2023 was Man Group, an estimated $5.21K added.
- The largest The Oncology Institute Warrant seller in Q2 2023 was Difesa Capital Management, an estimated $1.83K sold.
Based on aggregated 13F filings for Q2 2023.